Parnax Lab Ltd. Corporate Filings & Announcements

Latest corporate announcements and filings from Parnax Lab Ltd. on BSE

Load latest

Parnax Lab Ltd.

30 May 2024

130.00

1.60%

Board Meeting

PARNAX LAB LTD. - 506128 - Board Meeting Outcome for Board Meeting Outcome For Results-Audited Financial …

BSE India

Pursuant to the provisions of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) 2015, we wish to inform you that the Board of Directors of the Company at its meeting held today i.e., Thursday, 30th May, 2024, at its Registered Office, the Board inter alia has transacted the following business: 1. Considered and Approved the Standalone & Consolidated Audited Financial Results of the Company for the quarter and year ended 31st March, 2024, along with Auditor's Report thereon. 2. Declaration pursuant to Regulation 33(3)(d) as amended by the SEBI (Listing Obligations and Disclosure Requirements) (Amendment) Regulations, 2015. (A declaration is attached herewith as Annexure-I).

pdf

Parnax Lab Ltd.

22 May 2024, 05:32PM

130.00

1.60%

Board Meeting

PARNAX LAB LTD. - 506128 - Board Meeting Intimation for Board Meeting Intimation For The Meeting …

BSE India

PARNAX LAB LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/05/2024 ,inter alia, to consider and approve Pursuant to Regulation 29 of Listing Obligation and Disclosure Requirements, 2015, We hereby inform you that a meeting of the Board of Directors of the Company PARNAX LAB LIMITED is schedule to be held on Thursday, May 30, 2024, at the registered office of the Company, inter alia, to transact the following business: 1. To consider and approve Standalone and Consolidated Audited IND- AS Compliant Financial Results along with Auditor Report for the quarter (Q4) and Year ended 31st March, 2024, pursuant to Regulation 33 of Listing Obligation and Disclosure Requirement, 2015. 2. Any other business with the permission of the Chair. Kindly note that the approved results will be sent to you after the conclusion of the Board meeting

pdf

Parnax Lab Ltd.

12 Apr 2024

130.00

1.60%

Company Update

PARNAX LAB LTD. - 506128 - Certificate As Per Regulation 40(9) Of The Listing Obligations And …

BSE India

Please find enclosed herewith the Certificate as per Regulation 40(9), of LODR Regulation, 2015 for the year ended March 31, 2024. Kindly take the same on your record.

pdf

Parnax Lab Ltd.

11 Apr 2024

130.00

1.60%

Company Update

PARNAX LAB LTD. - 506128 - Compliance Certificate For The Period Ended March 31, 2024.

BSE India

Please find enclosed herewith the Certificate as per Regulation 7 (3) of the Listing Obligations and Disclosure Requirement Regulation, 2015, for the year ended March 31, 2024.

pdf

Parnax Lab Ltd.

08 Apr 2024

130.00

1.60%

Company Update

PARNAX LAB LTD. - 506128 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

BSE India

Pursuant to Regulation 74(5) of SEBI (Depository and Participants) Regulations, 2018, We have received confirmation certificate from our RTA i.e. Link Intime India Pvt. Ltd. that there were no dematerialization received during the quarter ended Mach 31, 2024. Also, enclosed Confirmation Certificate for the same.

pdf

Parnax Lab Ltd.

31 Mar 2024

130.00

1.60%

Company Update

PARNAX LAB LTD. - 506128 - Announcement under Regulation 30 (LODR)-Retirement

BSE India

Pursuant to Regulation 30 read with Schedule III of Security and Exchange Board of India (LODR) Regulation, 2015, we wish to inform you that Mr. Vinayak Desai (DIN: 03185850), has completed his second and final term as an Independent Director and consequently ceased to be a Director of the Company w.e.f. the close of business hours today i.e. 31st March, 2024. The above information is for your record.

pdf

Parnax Lab Ltd.

28 Mar 2024

130.00

1.60%

SAST

PARNAX LAB LTD. - 506128 - Closure of Trading Window

BSE India

We hereby inform you that in terms of Company''s Code for Prevention of Insider Trading framed under SEBI (Prohibited of Insider Trading) Regulations, 2015, the trading window for dealing in equity shares in the Company shall be closed for all the Insiders, Designated Persons, and their immediate Relatives of the Company w.e.f 01st April, 2024 upto the expiry of 48 hours after the Audited Financial Results for the Quarter and Year Ended March 31, 2024, become generally available to the public. The above is for your information and record.

pdf

Parnax Lab Ltd.

13 Feb 2024

130.00

1.60%

Result

PARNAX LAB LTD. - 506128 - Results-Unaudited Financial Results For The Quarter And Nine Months Ended …

BSE India

Kindly find attached herewith the Standalone and Consolidated Unaudited Financial Results for the Quarter and Nine Months Ended December 31, 2023, along with Limited Review Report.

pdf

Parnax Lab Ltd.

13 Feb 2024

130.00

1.60%

Board Meeting

PARNAX LAB LTD. - 506128 - Board Meeting Outcome for Results-Unaudited Financial Results For The Quarter …

BSE India

Pursuant to the provisions of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) 2015, we wish to inform you that the Board of Directors of the Company at its meeting held today i.e., Tuesday, 13th February, 2024, at its Registered Office, the Board inter alia has transacted the following business: 1. Considered and Approved the Standalone & Consolidated Un-Audited Financial Results of the Company for the quarter and nine months ended 31st December, 2023, along with Limited Review Report thereon. A Copy of Standalone & Consolidated Un-Audited Financial Results of the Company for the quarter and nine months ended 31st December, 2023, along with Limited Review Report thereon, pursuant to regulation 33 of SEBI (Listing Obligations and Disclosure Requirements) (Amendment) Regulations, 2015, is enclosed herewith. The meeting of the Board of Directors Commenced at 4.00 P.M. and Concluded at 04.30 P.M.

pdf

Parnax Lab Ltd.

03 Feb 2024

130.00

1.60%

Board Meeting

PARNAX LAB LTD. - 506128 - Board Meeting Intimation for Approval Of Unaudited Stand-Alone And Consolidated …

BSE India

PARNAX LAB LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/02/2024 ,inter alia, to consider and approve Standalone and Consolidated Un-audited IND- AS Compliant Financial Results along with Limited Review Report for the quarter (Q3) and Nine Months ended 31st December, 2023, pursuant to Regulation 33 of Listing Obligation and Disclosure Requirement, 2015 and any other business with the permission of the Chair. Kindly acknowledge the receipt of the same and Oblige

pdf

Is Parnax Lab Ltd. worth buying?

18 Votes:

Buy 72.22%

Sell 16.67%

Hold 11.11%